| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.085 | 0.1 |